Furthermore, the possible biomarkers related to gut microbiota were examined to better understand the therapeutic value of CKF which could modulate the microbiota-gut-brain axis via 5-HT-BDNF related pathways, and for IBS and depression-like behaviors. The gene discussed is BDNF; the disease is irritable bowel syndrome.